David Margrave is the founder of Lantern Pharma. He has spent two decades in senior executive roles within the life science sector.
David Margrave is the Chief Financial Officer at Lantern Pharma Inc., a clinical-stage biopharmaceutical company that utilizes AI, machine learning, and genomic data to enhance drug development, particularly in oncology. He has spent two decades in senior executive roles within the life science sector, including previously serving as President of BioNumerik Pharmaceuticals, Inc. Prior to that, he was a Partner in the technology group at the national law firm Andrews & Kurth LLP. Margrave holds a Bachelor of Arts and Science degree from Stanford University and a J.D. from The University of Texas School of Law.
Full founder directory · Investor directory · Company funding database · Fundraising library